Latest News Archive
Please select Category, Year, and then Month to display items
08 December 2021
|
Story Leonie Bolleurs
|
Photo Sonia Small
The Office for International Affairs at the UFS recently hosted a delegation from the Namibia University of Science and Technology. Pictured here are, from the left, front: Seithati Ramonaheng, UFS International Scholarships in the Office for International Affairs (OIA); Dr Erling Kavita; Dr Erold Naomab; Prof Yonas Bahta; back: Kagiso Ngake, UFS Partnerships in the OIA; Cornelius Hagenmeier; Zenzele Mdletshe, UFS Partnerships in the OIA; and Dr Falko Buschke, Centre for Environmental Management.
The
Office for International Affairs (OIA) at the University of the Free State (UFS) recently (25 November 2021) hosted a delegation from the
Namibia University of Science and Technology (NUST).
During deliberations, the two institutions discussed the possibility of formalising a partnership and it was agreed that the OIA would lead this process through its Partnership portfolio. The UFS and NUST are looking to work together and share information on the development of a COVID-19 vaccination policy, leveraging on the Germany/Namibia green hydrogen partnership, joining forces on the application for centres of excellence administered by the African Union, establishing staff and student exchange programmes, and intensifying their research collaborations.
Cornelius Hagenmeier, the Director of the Office for International Affairs (OIA) at the UFS, chaired the meeting with
Dr Erold Naomab, the Vice-Chancellor of NUST, and his adviser, Dr Erling Kavita.
Prof Yonas Bahta, Associate Professor in the UFS
Department of Agricultural Economics, and
Dr Falko Buschke, Senior Lecturer in the UFS
Centre for Environmental Management, also attended the meeting and reported on their existing academic collaborations with NUST.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”